The U.K. became the first country to approve Moderna Inc.’s Omicron-targeting Covid-19 vaccine as a booster shot, ahead of a planned fall vaccination campaign to shore up immune defenses against the virus.

The so-called bivalent vaccine is directed against both the original strain of SARS-CoV-2, the virus that causes Covid-19, and the first Omicron variant, also known as BA.1, which drove large waves of infection over the winter.

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Eli Lilly’s weight loss drug Zepbound found to reduce sleep apnea, company says

Eli Lilly’s weight loss drug Zepbound was found to reduce obstructive sleep…

Estelle Colored Glass Had a Big Year

In Stephanie Hall’s youth, afternoons spent treasure hunting with her grandmother in…

Watch top moments from Super Bowl 2023: Chiefs win; Rihanna is pregnant

IE 11 is not supported. For an optimal experience visit our site…

Digital World Acquisition Discloses Federal Subpoenas

Digital World Acquisition the special-purpose acquisition company that plans to merge with…